Evolent Health Q3 2023 Revenue $511M Beats $509.239M Estimate
Portfolio Pulse from Benzinga Newsdesk
Evolent Health reported its Q3 2023 revenue at $511M, surpassing the estimate of $509.239M.
November 02, 2023 | 8:35 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Evolent Health's Q3 2023 revenue exceeded estimates, which could positively impact the company's stock.
Evolent Health's revenue for Q3 2023 surpassed the estimated figure. This beat is likely to be viewed positively by investors, potentially leading to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100